Published
July 7, 2005
Velma
|
|
EpidemiologyPathophysiology Signs
and
|
||
| Hymenoptera venom allergy is an IgE-mediated hypersensitivity to the venom of insects within the insect order Hymenoptera. This allergic reaction may be caused by stings from a number of species in this insect order, occurring only in individuals who have previously been sensitized to Hymenoptera venom. | ||||
| Insect
sting allergy may develop at any age, and usually manifests after several
uneventful stings. The incidence of systemic reactions to Hymenoptera venom
is approximately 3% in adults.1 Although
children are stung more frequently than adults, systemic reactions occur
in only about 1% of individuals less than 17 years old, and many of these
reactions are relatively mild.2 Large local
reactions to Hymenoptera stings are more common in children, however, with
an estimated incidence of 20% and 10%, respectively, for children and adults.
The prevalence of insect sting allergy is twice as high in males as in females,3 and may be due to increased exposure rather than inherent susceptibility.
There is no clear association with other allergies, and only 30% of patients
with venom allergy are atopic.3 In addition,
insect sting allergy is statistically not more likely to occur in individuals
with a family history of sting reactions.2
At least 50 deaths per year occur in the United States from insect sting reactions,1 and many other sting fatalities may be unrecognized. Approximately one half of deaths occur in victims with no history of a prior sting reaction.4 Most fatalities (80%) occur in adults more than 40 years old, and only 2% occur in individuals less than 20 years old.4 Hymenoptera Stinging Insects: All the stinging insects belong to the insect order Hymenoptera, of which there are 16,000 species in North America. Fewer than 1% are responsible for human stings. All the species that are medically important belong to three families: Apidae, Vespidae, and Formicoidea.5 Only the females of each species have stingers, which are ovipositors that have lost their egg laying function and have been modified for stinging and envenomization. Most sting in defense of themselves and their nests, although some species also sting as a means of capturing their prey. Apidae
Family Vespidae
Family Yellow jackets account for most stings overall in the United States. They are especially prevalent in the Northeast and Midwest. They prefer to build their nests underground or in man-made structures low to the ground. They are notorious scavengers and frequently seek food in picnic areas and around trash containers. They are the most aggressive of all the vespids and will sting with little or no provocation during the late summer and early fall, when their colony numbers are largest and food supplies somewhat limited. New World hornets are closely related to yellow jackets; they are slightly larger but have similar coloring. Yellow hornets and white-faced (or bald-faced) hornets are actually aerial yellow jackets. They build large nests in trees or shrubs. Like yellow jackets, they are aggressive insects, particularly in the vicinity of their nests. Old World hornets, also known as European hornets, were accidentally introduced into the Eastern United States in the mid-1800s. These hornets usually build their nests in hollow trees and, unlike the other members of the Vespidae family, they frequently fly at night and are attracted to bright lights. Although they are much larger and more fearsome in appearance than the New World hornets, they are less aggressive. The population of these insects is gradually increasing, but they are still minor stinging threats. Paper wasps can be found throughout the United States, but most commonly in the southern states. Wasp colonies are relatively small and wasps are less aggressive insects than yellow jackets and hornets. Wasps tend to build their nests near human habitation (eg, under the eaves of houses, on porches, and below deck railings), and stinging encounters with these insects are therefore common. Formicidae
Family Hymenoptera Venoms: Venoms of the flying Hymenoptera are largely aqueous solutions containing proteins, peptides, and vasoactive amines. The toxic properties of venom are due to the above components collectively, and several of the venom proteins are allergenic. Immunologic cross-reactivity exists among the Hymenoptera venoms and is extensive between yellow jackets and hornets, moderate between wasps and other vespids, and minimal between honeybees and vespids. Imported fire ant venom is distinctly different from the other venoms and consists of a mixture of piperidine alkaloids and a small aqueous component containing allergenic proteins. One of these proteins is similar to one of the vespid allergens, and cross-reactivity between fire ants and vespids may occasionally occur.8 |
||||
| Both systemic and large local reactions to stinging insects are usually caused by IgE-mediated reactions to Hymenoptera venom. At least one prior sting is required to sensitize an individual to venom, and sensitization is more likely to occur following multiple simultaneous stings or subsequent stings occurring over a relatively short period of time. Once sensitization has occurred, a sting may cause mast cell and basophil degranulation, resulting in release of the histamine and other inflammatory mediators responsible for the signs and symptoms of both anaphylactic and some large local reactions. See Disease Management chapter on Anaphylaxis for further information on the pathophysiology of anaphylaxis. | ||||
Most Hymenoptera stings cause small local reactions of no significant medical consequence. These "normal" sting reactions are characterized by pain, itching, redness, and swelling at the sting site that resolve within several hours and are caused by the pharmacologic properties of the venom. Some large local reactions are caused by a late-phase IgE-dependent reaction that is mild initially but progresses after 12 to 24 hours to a diameter of more than 5 cm; these usually peak in intensity at 48 to 72 hours. These reactions are contiguous with the sting site but may occasionally involve an entire extremity. In rare cases, massive swelling may cause local anatomic compression. Large local sting reactions typically resolve gradually over 5 to 10 days. Virtually all individuals with large local reactions continue to have similar reactions with subsequent stings.9 This tendency is not modified with venom immunotherapy; therefore, patients with large local reactions are not candidates for further diagnostic evaluation (see below). Systemic reactions cause signs and symptoms in one or more organ systems and are almost always IgE-mediated. Systemic reactions cause a spectrum of manifestations ranging from cutaneous signs (pruritus, flushing, urticaria, angioedema) to respiratory involvement (cough, throat and/or chest tightness, dyspnea, wheezing) and cardiovascular compromise (dizziness, hypotension, unconsciousness), depending on the severity of the reaction. Gastrointestinal manifestations (nausea, vomiting, diarrhea) and uterine cramping may also occur occasionally. Cardiac anaphylaxis with manifestations of coronary vasospasm, arrhythmias, or bradycardia can also occur following stings even in individuals with no underlying cardiac disease. Systemic reactions usually cause signs and symptoms starting within minutes following a sting. In general, the sooner the symptoms occur, the more severe the reaction. Cutaneous signs and symptoms occur in 80% of adults and 95% of children with systemic reactions, but are the sole manifestation of the reaction in only 15% of adults. Isolated cutaneous reactions occur in 60% of children, however, who tend to have a more benign course than adults.10 Although symptoms involving the upper and lower airway occur with approximately the same frequency in children and adults, children have a much lower incidence of cardiovascular manifestations. Systemic reactions can also occur occasionally due to the toxic properties of Hymenoptera venom. They are most often associated with multiple simultaneous stings or underlying mastocytosis.11,12 These reactions may be indistinguishable from acute, systemic IgE-mediated reactions. Large numbers of stings can cause other serious reactions including rhabdomyolysis with renal failure, hemolysis, adult respiratory distress syndrome, and diffuse intravascular coagulation. Delayed reactions of unknown mechanism that rarely occur following stings include serum-sickness-like reactions, neuropathies, Guillain-Barré syndrome, myocarditis, and glomerulonephritis. |
||||
History Skin
Testing Venom testing is usually performed initially with prick tests. If results are negative, intradermal testing is used with a concentration in the range of 0.001 to 0.01 µg/mL. If the skin tests at these concentrations are still negative, the venom concentrations are increased by 10-fold increments until a positive skin test occurs, up to a maximum concentration of 1.0 µg/mL. Skin testing with higher concentrations is not performed because they are more likely to cause false-positive reactions due to the irritant properties of the venom. Because of the known cross-reactivities among the vespid venoms, skin tests are often positive to multiple venoms even when there has been a reaction to only a single insect sting. Although most patients with convincing histories of sting reactions have positive skin test results, some skin tests are negative. Skin test findings may be negative during the first 6 weeks after a sting due to a refractory period or "anergy,"14 and skin testing in these individuals should be repeated after 1 or 2 months. Negative skin tests may also occur in patients with a positive history who had remote sting reactions and have lost their sensitivity, and in individuals who had systemic non-IgE-mediated reactions due to toxic effects of the venom or underlying mastocytosis. Some patients with a positive history and a negative skin test do have venom-specific IgE antibodies in the serum, which can be detected by serologic testing using a radioallergosorbent test (RAST). Venom skin tests do not correlate perfectly with serologic venom-specific IgE assays, which are negative in approximately 20% of patients with positive skin tests. On the other hand, venom skin tests are negative in approximately 10% of subjects with detectable venom-specific IgE antibodies.15 Venom skin tests and RAST should be considered complementary, as neither test alone will detect all patients with insect sting allergy. In a 2003 rostrum paper, the Insect Committee of the American Academy of Allergy, Asthma, and Immunology recommended that the published 1999 practice parameter for stinging insect allergy revise the diagnostic algorithm for insect sting allergy to include IgE anti-venom serologic testing in patients with positive histories and negative skin tests.16 The updated 2004 practice parameter for stinging insect hypersensitivity recommends that for patients who have had a severe systemic reaction to an insect sting and who have negative venom skin test, repeat skin testing or in vitro testing for venom-specific IgE antibodies be performed before concluding that venom immunotherapy is not necessary.17 The level of sensitivity of venom skin testing or serologic testing does not accurately predict the severity of subsequent sting reactions. Low sensitivity on skin tests or RAST may be present in some individuals who have had near-fatal anaphylactic reactions, and the strongest reactions on skin tests are often in patients who have had only large local reactions to stings.18 In most cases, skin testing is not necessary in patients with histories of only large local reactions or in children who have had only mild systemic reactions limited to the skin (flushing, urticaria, angioedema), as their risk of having a more serious reaction subsequently is relatively low. |
||||
Treatment of Acute Reactions: Local reactions to insect stings are usually treated with cold packs, oral antihistamines, analgesics, and topical corticosteroids, all of which may help alleviate the associated itching and the local pain and swelling. A short course of an oral corticosteroid may be given for very large local reactions, and is most effective within the first few hours after a sting. Occasionally, large local reactions may be mistaken for cellulitis, and lymphangitic streaks may occur on the extremities as a result of drainage of inflammatory mediators. When these reactions occur in the 24 to 48 hours after a sting, infection is extremely unlikely, and treatment should include cold packs and an oral corticosteroid given for 4 to 5 days. Treatment of Systemic Reactions: Mild systemic reactions manifested only by cutaneous symptoms may respond to antihistamines alone. Most systemic reactions, however, require treatment with epinephrine. Patients with any signs or symptoms of upper or lower airway obstruction or hypotension should immediately receive aqueous epinephrine intramuscularly,19 emergency medical attention and treatment, and close observation for a 4 hours or longer depending on the reaction severity.20 Some patients may require additional doses of epinephrine and/or other treatment for severe anaphylactic reactions. The recommended dose of epinephrine is 0.3 to 0.5 mg (0.3 to 0.5 mL of 1:1000 weight/volume solution) for adults, and 0.01mg/kg (maximum of 0.3 mg) or 0.01mL/kg of 1:1000 weight/volume solution (maximum of 0.3mL) for children. Delay in the use of epinephrine has contributed to fatalities and some patients with anaphylactic shock are resistant to epinephrine. Individuals who are taking beta-blockers can also be resistant to the use of epinephrine and may require large amounts of intravenous fluids and glucagon to reverse anaphylaxis.See chapter on Anaphylaxis for additional information on treatment of anaphylaxis. |
||||
Prevention: After acute care of
a sting reaction, patients should be given a prescription for an epinephrine
autoinjector, referral to an allergist/immunologist, and instructions
on prevention of insect stings. Epinephrine autoinjectors are available
in only two strengths (EpiPen 0.3 mg and EpiPen Jr. 0.15 mg). The EpiPen
Jr. is usually preferred in children weighing less than 25 kg. Patients
and their caretakers should be given instructions on the correct technique
for use of the device and reminded to replace it at expiration. Patients
should be advised to minimize high-risk exposure to stinging insects that
may occur through lawn and garden work, trash bins, and eating and drinking
outdoors. Stings to the mouth and tongue may occur from ingesting food
or flavored drinks that are being scavenged by yellow jackets. Additional
information on avoidance as well as identification of insects is available
at www.aaaai.org/patients/publicedmat/ Natural History: The risk that a future sting will cause an allergic reaction depends on the history as well as the individual's immunologic status. For adults who have had a severe systemic reaction and who have positive skin tests or RAST, the risk of a subsequent systemic reaction is approximately 60%,21 but it is significantly less, approximately 20%, if the prior reaction caused only cutaneous symptoms (flushing, urticaria, angioedema).22 The outcomes of subsequent stings may vary within an individual patient due to variations in the insect species, the amount of allergen delivered, and fluctuation in the patient's immunologic and physiologic status. The risk of a recurrent systemic sting reaction is higher in patients with honeybee allergy than in those allergic to vespids.23 Patients who have had severe reactions have a higher risk of recurrent sting reactions than do those who have sustained milder reactions, and adults have a higher risk of recurrent systemic reactions than do children. In general, individuals have a stereotypical response to stings that does not vary greatly from one sting to another; despite popular opinion, it is unusual for patients to have increasingly severe reactions with each subsequent sting. Children who have had mild systemic reactions limited to the skin have only a 10% risk of subsequent systemic reaction, and less than 1% risk of having a reaction more severe than the prior one.23,24 The risk of recurrence of a severe systemic reaction in a child is significantly higher, approximately 40%,22 although still lower than for a comparable reaction in an adult. Both adults and children who have had only large local reactions have a relatively low risk (5% to 10%)9,25 of having a systemic reaction with a subsequent sting, although most of them will continue to have large local reactions. Venom Immunotherapy: Indications Selection
of Venoms and Dosing Venom immunotherapy is initiated at a very small dose of venom that is increased to the full maintenance dose according to a scheduled recommended by the laboratory that prepared the venom extract and/or the prescribing physician. Adverse reactions are usually no more common with rapid dosage regimens that can achieve maintenance doses in days or weeks than with traditional regimens that take 4 to 6 months.26,27 The standard recommended maintenance dose is 100 µg for each venom to which the patient has a positive skin test. This dose was originally selected because it was approximately twice the amount of venom in a single honeybee sting (50 µg). The amount of venom injected by a vespid varies significantly, with estimates ranging from 2 to 20 µg per sting.28 Maintenance venom immunotherapy is usually administered at 4-week intervals for at least 1 year. Several studies have shown that the maintenance interval may be extended to 6 to 8 weeks over several years in most patients. Some physicians elect to repeat skin tests every 2 to 3 years while patients are receiving maintenance therapy, although only 50% to 60% of patients will have a negative skin test even after 7 to 10 years of therapy.29 Efficacy
of Venom Immunotherapy Safety
of Immunotherapy Patients who are taking beta-blockers are at increased risk for more serious anaphylaxis if they have a systemic reaction during venom immunotherapy in part because they are more likely to be refractory to treatment with epinephrine.17,36 An effort should be made to substitute alternative medication (eg, diuretic or calcium channel blocker for treatment of hypertension) before initiating immunotherapy in these patients. As with inhalant immunotherapy, maintenance venom immunotherapy can be continued during pregnancy although it is not recommended that it be initiated during pregnancy.36,37 Venom immunotherapy should be performed only in an office or clinic that is prepared to give immediate treatment of anaphylaxis, and patients must remain in the office for at least 30 minutes before going home after an injection. Duration
of Immunotherapy and Outcomes |
||||
|
